Publications by authors named "Judith Gulikers"

Claim this Profile
R
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, Ewoudt M W van de Garde, Egbert F Smit, Judith L Gulikers

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The food environment through the eyes of adolescents: exploring socioecological factors and opportunities for healthy and sustainable food choices.
Anouk Mesch, Femke Hoefnagels, Judith Gulikers, Renate Wesselink, Laura H H Winkens

BMC Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants, behaviour change techniques and pedagogical approaches used in secondary school-based food and nutrition programmes: a qualitative study of the SWITCH project.
Anouk Mesch, Madelief Engels, Sanne Raghoebar, Laura H H Winkens, Judith Gulikers

BMC Public Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.
Judith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers, Safiye Dursun, Vivianne Tjan-Heijnen

Ther Adv Med Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer.
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens

Br J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced -Mutated NSCLC.
Judith L Gulikers, G D Marijn Veerman, Merel Jebbink, Paul D Kruithof, Christi M J Steendam

JTO Clin Res Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experts' perceptions on motivators and barriers of healthy and sustainable dietary behaviors among adolescents: The SWITCH project.
Sanne Raghoebar, Anouk Mesch, Judith Gulikers, Laura H H Winkens, Renate Wesselink

Appetite· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer.
Ard van Veelen, G D Marijn Veerman, Marjon V Verschueren, Judith L Gulikers, Christi M J Steendam

Int J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
' by Di Fant, V., del Pozo, M., Gulikers, J. and Paparrizos, S.
Valeria Di Fant, Maria Del Pozo, Judith Gulikers, Spyridon Paparrizos

Heliyon· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs.
Paul D Kruithof, Yvo M de Beer, Judith L Gulikers, Leo M L Stolk, Lizza E L Hendriks

J Chromatogr B Analyt Technol Biomed Life Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results.
Marjon V Verschueren, Talitha Dijs, Judith L Gulikers, Ard van Veelen, Sander Croes

Immunotherapy· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma.
Judith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz, Yvo M de Beer, Mariëlle Slikkerveer

Biomed Chromatogr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial.
Ard van Veelen, Judith Gulikers, Lizza E L Hendriks, Safiye Dursun, Juanita Ippel

Lung Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary school teachers' use of online formative assessment during COVID-19 lockdown: Experiences and lessons learned.
Maria Joanna Veugen, Judith Theresia Maria Gulikers, Perry den Brok

J Comput Assist Learn· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer.
Leila S Otten, Berber Piet, Michel M van den Heuvel, Catia Marzolini, Robin M J M van Geel, Judith L Gulikers

Eur Respir Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab exposure in a hemodialysis patient with metastatic melanoma.
Judith L Gulikers, Sander Croes, Marco J W Schreurs, Elisabeth J R Litjens, Maureen J B Aarts

Melanoma Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilitating evaluations of innovative, competence-based assessments: creating understanding and involving multiple stakeholders.
Judith T M Gulikers, Liesbeth K J Baartman, Harm J A Biemans

Eval Program Plann· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis